Traws Pharma, Inc. (NASDAQ: TRAW)
$4.4500
-0.0146 ( -1.33% ) 3.3K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$4.4500
Previous close
$4.4646
Volume
3.3K
Market cap
$13.68M
Day range
$4.3810 - $4.6700
52 week range
$4.1550 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| pre | Proxies and info statements | 4 | Jun 27, 2024 |
| 8-k | 8K-related | 13 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 20, 2024 |
| 8-k/a | 8K-related | 17 | Jun 17, 2024 |
| 8-k | 8K-related | 14 | May 22, 2024 |
| 8-k | 8K-related | 14 | May 16, 2024 |
| 10-q | Quarterly Reports | 64 | May 15, 2024 |
| 10-k/a | Quarterly Reports | 15 | Apr 29, 2024 |
| 8-k | 8K-related | 51 | Apr 16, 2024 |
| 3/a | Insider transactions | 1 | Apr 12, 2024 |